First Opinion

First Opinion Adina Wise

Who should get to see the neurologist first: the sick or the at-risk?

First Opinion Guy David

Why Harvard, Penn, and Columbia have turned to M.D.s for leadership in troubled times

Torie Bosch

STAT readers on mask bans, cancer screening, and empathy and AI

First Opinion Daniel Morgan

Why you may not need a checkup every year

First Opinion Sophia Hua

A harm-reduction approach to eating out

First Opinion Sophie Zaaijer

In drug development, diversity must be extended to preclinical research

First Opinion Adewole Adamson, Vishal Patel, and H. Gilbert Welch

Doing more cancer screening won’t reduce Black-white health disparities

First Opinion Anand Kumar

What’s going on in Joe Biden’s brain?

First Opinion Michael Banks

Improving the FDA-EMA parallel scientific advice program to advance complex generics

First Opinion Kaitlin Costello

Mask bans disenfranchise millions of Americans with disabilities

First Opinion Jim Downs

Graphic mpox images to educate the public are deeply problematic

First Opinion Steffie Woolhandler, David U. Himmelstein, Elizabeth Schrier, and Hope Schwartz

Private equity: health care’s vampire

Letters to the editor Patrick Skerrett

First Opinion readers on Noah Lyles and Covid-19, the dearth of geriatricians, PBMs, and more

First Opinion Sarah Emond

STAT Plus: What the newly released Medicare prices for 10 drugs do and don’t tell us

First Opinion Peter Staley

Gilead must be held accountable for the harm caused by ‘patent hopping’ an HIV treatment

First Opinion Evan Selinger and Thomas Carroll

Can AI help ease medicine’s empathy problem?

First Opinion David Introcaso

HHS says it is working to stop the climate crisis. But it’s really just climate washing

First Opinion Nicholas DeVito

Ultra-processed foods: the tobacco of the 21st century?

First Opinion Gregory A. Poland

Better safety studies could restore America’s confidence in vaccines

First Opinion Deborah M. Stein and Robert V. O'Toole

Aspirin after a broken bone: health equity in a $5 bottle

First Opinion Suzanne Robotti

The FDA should withdraw approval of more than 400 tainted medicines

First Opinion T. Joseph Mattingly II, David A. Hyman, and Ge Bai

Some ‘inconvenient’ truths about pharmacy benefit managers

First Opinion Susannah Baruch

Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health

First Opinion Giulia Balconi

Controlling obesity is a noble goal. Controlling mpox is a far more urgent one

Letters to the editor Patrick Skerrett

First Opinion readers respond to essays on right to try lies, pharma execs, and more

First Opinion Arthur L. Caplan

Noah Lyles’ collapse with Covid: How not to manage health at the Olympics

First Opinion Anne N. Thorndike

Small changes in food ‘choice environments’ in stores can make a healthy difference

First Opinion David Weill

Medicine needs fiction, especially now

First Opinion Evelyn Tenenbaum and Jed Adam Gross

Removing barriers to split liver transplants will save lives